Copyright Reports & Markets. All rights reserved.

Global Pranlukast Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope of Pranlukast
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Pranlukast Consumption Value by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Min Purity Less Than 98%
    • 1.3.3 Min Purity 98%-99%
    • 1.3.4 Min Purity More Than 99%
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Pranlukast Consumption Value by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Research
    • 1.4.3 Medical
  • 1.5 Global Pranlukast Market Size & Forecast
    • 1.5.1 Global Pranlukast Consumption Value (2018 & 2022 & 2029)
    • 1.5.2 Global Pranlukast Sales Quantity (2018-2029)
    • 1.5.3 Global Pranlukast Average Price (2018-2029)

2 Manufacturers Profiles

  • 2.1 Merck
    • 2.1.1 Merck Details
    • 2.1.2 Merck Major Business
    • 2.1.3 Merck Pranlukast Product and Services
    • 2.1.4 Merck Pranlukast Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Merck Recent Developments/Updates
  • 2.2 Cayman Chemical
    • 2.2.1 Cayman Chemical Details
    • 2.2.2 Cayman Chemical Major Business
    • 2.2.3 Cayman Chemical Pranlukast Product and Services
    • 2.2.4 Cayman Chemical Pranlukast Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Cayman Chemical Recent Developments/Updates
  • 2.3 TCI
    • 2.3.1 TCI Details
    • 2.3.2 TCI Major Business
    • 2.3.3 TCI Pranlukast Product and Services
    • 2.3.4 TCI Pranlukast Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 TCI Recent Developments/Updates
  • 2.4 Selleck Chemicals
    • 2.4.1 Selleck Chemicals Details
    • 2.4.2 Selleck Chemicals Major Business
    • 2.4.3 Selleck Chemicals Pranlukast Product and Services
    • 2.4.4 Selleck Chemicals Pranlukast Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Selleck Chemicals Recent Developments/Updates
  • 2.5 Bio-Techne
    • 2.5.1 Bio-Techne Details
    • 2.5.2 Bio-Techne Major Business
    • 2.5.3 Bio-Techne Pranlukast Product and Services
    • 2.5.4 Bio-Techne Pranlukast Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Bio-Techne Recent Developments/Updates
  • 2.6 LifeSpan BioSciences
    • 2.6.1 LifeSpan BioSciences Details
    • 2.6.2 LifeSpan BioSciences Major Business
    • 2.6.3 LifeSpan BioSciences Pranlukast Product and Services
    • 2.6.4 LifeSpan BioSciences Pranlukast Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 LifeSpan BioSciences Recent Developments/Updates
  • 2.7 AbMole
    • 2.7.1 AbMole Details
    • 2.7.2 AbMole Major Business
    • 2.7.3 AbMole Pranlukast Product and Services
    • 2.7.4 AbMole Pranlukast Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 AbMole Recent Developments/Updates
  • 2.8 Abcam
    • 2.8.1 Abcam Details
    • 2.8.2 Abcam Major Business
    • 2.8.3 Abcam Pranlukast Product and Services
    • 2.8.4 Abcam Pranlukast Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Abcam Recent Developments/Updates
  • 2.9 Spectrum Chemical
    • 2.9.1 Spectrum Chemical Details
    • 2.9.2 Spectrum Chemical Major Business
    • 2.9.3 Spectrum Chemical Pranlukast Product and Services
    • 2.9.4 Spectrum Chemical Pranlukast Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Spectrum Chemical Recent Developments/Updates
  • 2.10 LGC
    • 2.10.1 LGC Details
    • 2.10.2 LGC Major Business
    • 2.10.3 LGC Pranlukast Product and Services
    • 2.10.4 LGC Pranlukast Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 LGC Recent Developments/Updates
  • 2.11 Santa Cruz Biotechnology
    • 2.11.1 Santa Cruz Biotechnology Details
    • 2.11.2 Santa Cruz Biotechnology Major Business
    • 2.11.3 Santa Cruz Biotechnology Pranlukast Product and Services
    • 2.11.4 Santa Cruz Biotechnology Pranlukast Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Santa Cruz Biotechnology Recent Developments/Updates
  • 2.12 Focus Biomolecules
    • 2.12.1 Focus Biomolecules Details
    • 2.12.2 Focus Biomolecules Major Business
    • 2.12.3 Focus Biomolecules Pranlukast Product and Services
    • 2.12.4 Focus Biomolecules Pranlukast Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 Focus Biomolecules Recent Developments/Updates
  • 2.13 Biosynth Carbosynth
    • 2.13.1 Biosynth Carbosynth Details
    • 2.13.2 Biosynth Carbosynth Major Business
    • 2.13.3 Biosynth Carbosynth Pranlukast Product and Services
    • 2.13.4 Biosynth Carbosynth Pranlukast Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.13.5 Biosynth Carbosynth Recent Developments/Updates
  • 2.14 BOC Sciences
    • 2.14.1 BOC Sciences Details
    • 2.14.2 BOC Sciences Major Business
    • 2.14.3 BOC Sciences Pranlukast Product and Services
    • 2.14.4 BOC Sciences Pranlukast Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.14.5 BOC Sciences Recent Developments/Updates
  • 2.15 Ark Pharm
    • 2.15.1 Ark Pharm Details
    • 2.15.2 Ark Pharm Major Business
    • 2.15.3 Ark Pharm Pranlukast Product and Services
    • 2.15.4 Ark Pharm Pranlukast Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.15.5 Ark Pharm Recent Developments/Updates
  • 2.16 Aladdin
    • 2.16.1 Aladdin Details
    • 2.16.2 Aladdin Major Business
    • 2.16.3 Aladdin Pranlukast Product and Services
    • 2.16.4 Aladdin Pranlukast Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.16.5 Aladdin Recent Developments/Updates

3 Competitive Environment: Pranlukast by Manufacturer

  • 3.1 Global Pranlukast Sales Quantity by Manufacturer (2018-2023)
  • 3.2 Global Pranlukast Revenue by Manufacturer (2018-2023)
  • 3.3 Global Pranlukast Average Price by Manufacturer (2018-2023)
  • 3.4 Market Share Analysis (2022)
    • 3.4.1 Producer Shipments of Pranlukast by Manufacturer Revenue ($MM) and Market Share (%): 2022
    • 3.4.2 Top 3 Pranlukast Manufacturer Market Share in 2022
    • 3.4.2 Top 6 Pranlukast Manufacturer Market Share in 2022
  • 3.5 Pranlukast Market: Overall Company Footprint Analysis
    • 3.5.1 Pranlukast Market: Region Footprint
    • 3.5.2 Pranlukast Market: Company Product Type Footprint
    • 3.5.3 Pranlukast Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Pranlukast Market Size by Region
    • 4.1.1 Global Pranlukast Sales Quantity by Region (2018-2029)
    • 4.1.2 Global Pranlukast Consumption Value by Region (2018-2029)
    • 4.1.3 Global Pranlukast Average Price by Region (2018-2029)
  • 4.2 North America Pranlukast Consumption Value (2018-2029)
  • 4.3 Europe Pranlukast Consumption Value (2018-2029)
  • 4.4 Asia-Pacific Pranlukast Consumption Value (2018-2029)
  • 4.5 South America Pranlukast Consumption Value (2018-2029)
  • 4.6 Middle East and Africa Pranlukast Consumption Value (2018-2029)

5 Market Segment by Type

  • 5.1 Global Pranlukast Sales Quantity by Type (2018-2029)
  • 5.2 Global Pranlukast Consumption Value by Type (2018-2029)
  • 5.3 Global Pranlukast Average Price by Type (2018-2029)

6 Market Segment by Application

  • 6.1 Global Pranlukast Sales Quantity by Application (2018-2029)
  • 6.2 Global Pranlukast Consumption Value by Application (2018-2029)
  • 6.3 Global Pranlukast Average Price by Application (2018-2029)

7 North America

  • 7.1 North America Pranlukast Sales Quantity by Type (2018-2029)
  • 7.2 North America Pranlukast Sales Quantity by Application (2018-2029)
  • 7.3 North America Pranlukast Market Size by Country
    • 7.3.1 North America Pranlukast Sales Quantity by Country (2018-2029)
    • 7.3.2 North America Pranlukast Consumption Value by Country (2018-2029)
    • 7.3.3 United States Market Size and Forecast (2018-2029)
    • 7.3.4 Canada Market Size and Forecast (2018-2029)
    • 7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

  • 8.1 Europe Pranlukast Sales Quantity by Type (2018-2029)
  • 8.2 Europe Pranlukast Sales Quantity by Application (2018-2029)
  • 8.3 Europe Pranlukast Market Size by Country
    • 8.3.1 Europe Pranlukast Sales Quantity by Country (2018-2029)
    • 8.3.2 Europe Pranlukast Consumption Value by Country (2018-2029)
    • 8.3.3 Germany Market Size and Forecast (2018-2029)
    • 8.3.4 France Market Size and Forecast (2018-2029)
    • 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
    • 8.3.6 Russia Market Size and Forecast (2018-2029)
    • 8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

  • 9.1 Asia-Pacific Pranlukast Sales Quantity by Type (2018-2029)
  • 9.2 Asia-Pacific Pranlukast Sales Quantity by Application (2018-2029)
  • 9.3 Asia-Pacific Pranlukast Market Size by Region
    • 9.3.1 Asia-Pacific Pranlukast Sales Quantity by Region (2018-2029)
    • 9.3.2 Asia-Pacific Pranlukast Consumption Value by Region (2018-2029)
    • 9.3.3 China Market Size and Forecast (2018-2029)
    • 9.3.4 Japan Market Size and Forecast (2018-2029)
    • 9.3.5 Korea Market Size and Forecast (2018-2029)
    • 9.3.6 India Market Size and Forecast (2018-2029)
    • 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
    • 9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

  • 10.1 South America Pranlukast Sales Quantity by Type (2018-2029)
  • 10.2 South America Pranlukast Sales Quantity by Application (2018-2029)
  • 10.3 South America Pranlukast Market Size by Country
    • 10.3.1 South America Pranlukast Sales Quantity by Country (2018-2029)
    • 10.3.2 South America Pranlukast Consumption Value by Country (2018-2029)
    • 10.3.3 Brazil Market Size and Forecast (2018-2029)
    • 10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

  • 11.1 Middle East & Africa Pranlukast Sales Quantity by Type (2018-2029)
  • 11.2 Middle East & Africa Pranlukast Sales Quantity by Application (2018-2029)
  • 11.3 Middle East & Africa Pranlukast Market Size by Country
    • 11.3.1 Middle East & Africa Pranlukast Sales Quantity by Country (2018-2029)
    • 11.3.2 Middle East & Africa Pranlukast Consumption Value by Country (2018-2029)
    • 11.3.3 Turkey Market Size and Forecast (2018-2029)
    • 11.3.4 Egypt Market Size and Forecast (2018-2029)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
    • 11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

  • 12.1 Pranlukast Market Drivers
  • 12.2 Pranlukast Market Restraints
  • 12.3 Pranlukast Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry
  • 12.5 Influence of COVID-19 and Russia-Ukraine War
    • 12.5.1 Influence of COVID-19
    • 12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Pranlukast and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Pranlukast
  • 13.3 Pranlukast Production Process
  • 13.4 Pranlukast Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Pranlukast Typical Distributors
  • 14.3 Pranlukast Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Pranlukast is an orally bioavailable cysteinyl leukotriene 1 (CysLT1) receptor antagonist.
    According to our (Global Info Research) latest study, the global Pranlukast market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
    This report is a detailed and comprehensive analysis for global Pranlukast market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
    Key Features:
    Global Pranlukast market size and forecasts, in consumption value ($ Million), sales quantity (Kg), and average selling prices (K USD/Kg), 2018-2029
    Global Pranlukast market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Kg), and average selling prices (K USD/Kg), 2018-2029
    Global Pranlukast market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Kg), and average selling prices (K USD/Kg), 2018-2029
    Global Pranlukast market shares of main players, shipments in revenue ($ Million), sales quantity (Kg), and ASP (K USD/Kg), 2018-2023
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Pranlukast
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Pranlukast market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, Cayman Chemical, TCI, Selleck Chemicals and Bio-Techne, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
    Market Segmentation
    Pranlukast market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Min Purity Less Than 98%
    Min Purity 98%-99%
    Min Purity More Than 99%
    Market segment by Application
    Research
    Medical
    Major players covered
    Merck
    Cayman Chemical
    TCI
    Selleck Chemicals
    Bio-Techne
    LifeSpan BioSciences
    AbMole
    Abcam
    Spectrum Chemical
    LGC
    Santa Cruz Biotechnology
    Focus Biomolecules
    Biosynth Carbosynth
    BOC Sciences
    Ark Pharm
    Aladdin
    Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Pranlukast product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Pranlukast, with price, sales, revenue and global market share of Pranlukast from 2018 to 2023.
    Chapter 3, the Pranlukast competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Pranlukast breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
    Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Pranlukast market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
    Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Pranlukast.
    Chapter 14 and 15, to describe Pranlukast sales channel, distributors, customers, research findings and conclusion.

    Buy now